Year: 2019
Type: review
Abstract: Neurodegenerative diseases (NDs) are a wide class of disorders of the central nervous system (CNS) with unknown etiology. Several factors were hypothesized to be involved in the pathogenesis of these diseases, including genetic and environmental factors. Many of these diseases show a sex prevalence and sex steroids were shown to have a role in the progression of specific forms of neurodegeneration. Estrogens were reported to be neuroprotective through their action on cognate nuclear and membrane receptors, while adverse effects of male hormones have been described on neuronal cells, although some data also suggest neuroprotective activities. The response of the CNS to sex steroids is a complex and integrated process that depends on (i) the type and amount of the cognate steroid receptor and (ii) the target cell type-either neurons, glia, or microglia. Moreover, the levels of sex steroids in the CNS fluctuate due to gonadal activities and to local metabolism and synthesis. Importantly, biochemical processes involved in the pathogenesis of NDs are increasingly being recognized as different between the two sexes and as influenced by sex steroids. The aim of this review is to present current state-of-the-art understanding on the potential role of sex steroids and their receptors on the onset and progression of major neurodegenerative disorders, namely, Alzheimer's disease, Parkinson's diseases, amyotrophic lateral sclerosis, and the peculiar motoneuron disease spinal and bulbar muscular atrophy, in which hormonal therapy is potentially useful as disease modifier.
Source: Endocrine Reviews
Institution: University of Milan
Language: English
Subfield: Endocrinology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,750
Funders: European Molecular Biology Organization, Università degli Studi di Milano, EU Joint Programme – Neurodegenerative Disease Research, European Commission, Fondazione Telethon, Fondazione Cariplo, Ministero della Salute, Ministero dell’Istruzione, dell’Università e della Ricerca, Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica, Regione Lombardia, Fondazione Regionale per la Ricerca Biomedica, National Institutes of Health, Agenzia Italiana del Farmaco, Ministero della Salute, National Institute on Aging
Awards: G1184370674, G2817920283, G2852025967, G297937679, THE INTERPLAY BETWEEN THE “RNA/PROTEIN QUALITY CONTROL SYSTEM” AND “EXOSOMES” AS A SPREADING MECHANISM IN AMYOTROPHIC LATERAL SCLEROSIS [EX_ALS], G3207356259, From RNA to Protein toxicity in motorneuron diseases, G393177772, G493698437, RAN-translation of normal and expanded nucleotide repeat containing transcripts to neurotoxic polypetides in neurodegenerative diseases, G5171413337, Menopause: Decreased Response to Increasing Inflammation, G5382016613, G5702163051, G6123909991, Ruolo dell'immunità innata nell'effeto neuroprotettivo degli estrogeni: meccanismi molecolari e rilevanza per la malattia di Parkinson, G7021204715, Imaging of Neuroinflammation in Neurodegenerative Diseases, G7155227525, G7591890595, G8563002755, ERA-NET for establishing synergies between the Joint Programming on Neurodegenerative Diseases Research and Horizon 2020, G917473516
OpenAlex ID: W2976289506
